Royalty Pharma plc Profile Avatar - Palmy Investing

Royalty Pharma plc

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various bioph…
Biotechnology
US, New York [HQ]

Filings / Resources

Link Index · Filing Reader · 10K/10Q
Loading may take some time.
SEC
2024-03-31 2023-12-31 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30
Transcripts

Gather insights into the latest earnings call through our transcripts.

Other Docs/Resources
Transcripts Investor Relations EDGAR RPRX's Industry Healthcare Analysis Biotechnology Analysis US Analysis New York Analysis
End of RPRX's Analysis
CIK: 1802768 CUSIP: G7709Q104 ISIN: GB00BMVP7Y09 LEI: - UEI: -
Secondary Listings
RPRX has no secondary listings inside our databases.